Navigation Links
FDA: Lower Ambien's Dose to Prevent Drowsy Driving
Date:1/11/2013

By Amanda Gardner
HealthDay Reporter

THURSDAY, Jan. 10 (HealthDay News) -- The U.S. Food and Drug Administration announced Thursday that it is asking manufacturers of sleep medications containing zolpidem -- including Ambien -- to lower the recommended doses and to provide more safety information to patients.

These sleep medications include Ambien, Ambien CR, Edluar and Zolpimist, as well as generic versions of Ambien and Ambien CR.

Officials are concerned that blood levels of zolpidem are high enough the morning after taking the drugs to continue to impair one's ability to perform certain activities.

"The purpose of the lowering is to help decrease the risk of next-morning impairment of activities that require alertness," said Dr. Ellis Unger, director of the Office of Drug Evaluation I at the FDA's Center for Drug Evaluation and Research. "We're particularly concerned about driving. A large fraction of the population drives and driving is an inherently dangerous activity."

Lowering the nighttime dose means there will be less residual drug in the blood by the time the person wakes up. Extended-release forms of the drugs tend to stay in the body longer.

The FDA has told manufacturers that recommended doses for women should be cut in half, from 10 milligrams to 5 milligrams for immediate-release products (Ambien, Edluar and Zolpimist) and from 12.5 mg to 6.25 mg for extended-release products (Ambien CR).

For men, the agency has asked manufacturers to change the labeling to recommend that doctors and other health-care professionals consider prescribing lower doses, meaning 5 mg for immediate-release products and 6.25 mg for extended-release products.

In explaining the different recommendations for men and women, Unger said at a midday news conference that "women appear to be more susceptible to risk for next-morning impairment because they eliminate zolpidem from their bodies more slowl
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Reductions in Wood-Burning Stoves Tied to Lower Death Rates
2. Corporate Whistle Blower Center Now Urges Physicians Medical Device and Drug Industry Insiders To Step Up-If They Have Proof Of Serious Wrongdoing or Overbilling
3. Common Blood Pressure Drugs Might Lower Dementia Risk
4. Low Vitamin D in Early Pregnancy Tied to Lower Birth Weight
5. Corporate Whistle Blower Center Now Urges Physicians to Become a Whistleblower if They Have Proof a Medical Device or a Drug Product was Defective-and it was Sold Anyway
6. Corporate Whistle Blower Center Now Urges Physicians, Medical Device or Drug Insiders With Proof A Company Knowingly Sold A Bad Product to Become a Whistleblower
7. Astro Clairvoyant Norah Guide with Premium Astrology Helps Friends and Followers Predict and Understand Current Events At No Cost
8. New Diabetes Guidelines May Lower Patient Medical Bills
9. Patients with diabetes may not receive best treatment to lower heart disease risk
10. Corporate Whistle Blower Center Now Urges Medical Industry Insiders to Blow the Whistle if They Can Prove a Medical Product was Defective and Their Company Sold it Anyway
11. EPA Lowers Permissible Soot Levels in Air
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA: Lower Ambien's Dose to Prevent Drowsy Driving
(Date:9/16/2014)... 16, 2014 LiveOps, the global ... solutions, announced today that the company has received ... for the creation of a social learning ecosystem ... Hall Group honors companies that have successfully developed ... tools that have helped companies achieve measurable results. ...
(Date:9/16/2014)... 16, 2014 Former Major League Baseball ... undergoing successful heart transplantation surgery at Allegheny General Hospital ... spent most of his 16-year baseball career with the ... commentator for Root Sports Pittsburgh, was discharged home on ... Bailey, MD, surgical director of AGH’s heart transplant program. ...
(Date:9/16/2014)... September 15, 2014Patients with inoperable, early-stage lung cancer ... a five-year survival rate of 40 percent, according ... for Radiation Oncology,s (ASTRO,s) 56th Annual Meeting. Such ... historically conventional RT resulted in poor tumor control ... is an update of RTOG 0236, originally published ...
(Date:9/16/2014)... who tend to be on the heavy side. Researchers ... found that seven in every ten obese adults underestimate ... this mistake much less often. Mothers of overweight or ... as youngsters misjudge their obese mothers, size, says lead ... a study in the Journal of General Internal ...
(Date:9/16/2014)... Poster Discussion abstracts to be presented at the ESMO ... September 2014 at 12:00 (CEST) to give you a ... European medical oncology Congress, under the leading theme Precision ... point where genuinely targeted therapy is now possible for ... we are all working towards a common goal --improved ...
Breaking Medicine News(10 mins):Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 3Health News:Poor body size judgement can lead to increased tolerance of obesity 2Health News:ESMO 2014 Congress Preview 2
... Chief Financial Officer, OAKLAND, Calif., July 1 ... ("WorldHeart" or the "Corporation") announced today,that, on June ... NASDAQ Stock,Market stating that the Corporation does not ... requires the Corporation to maintain,a minimum market value ...
... Somanetics Corporation,(Nasdaq: SMTS ) announced today that ... up to an additional $15 million of its common,shares ... shares). Purchases may be,made from time to time in ... timing and amount of, and purposes for, any,purchases will ...
... development, researcher says , , TUESDAY, July 1 (HealthDay News) ... numerous painful interventions, not enough is being done to ... 42,413 painful procedures included in this study, only 2 ... percent received non-pharmacological pain therapy. That means about four ...
... PHILADELPHIA - Researchers at the University of Pennsylvania School ... vaccinate against avian flu. By delivering vaccine via DNA ... minute electric pulse, researchers have immunized experimental animals against ... for the build up of vaccine reserves that could ...
... July 1, 2008 Researchers have found that a ... varieties of adult rheumatoid arthritis is also present in ... responsible gene may be a "master switch" that helps ... Children,s Hospital of Philadelphia reported on the link between ...
... close to patient pinpointed who was likely to progress to ... questionnaire may help in both diagnosing older adults facing dementia ... living. , The Everyday Cognition instrument consists of 39 questions ... , "There have been a number of studies that show ...
Cached Medicine News:Health News:WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market 2Health News:WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market 3Health News:Somanetics Announces Share Repurchase Program Increased By $15 Million 2Health News:Newborns in Intensive Care Often Exposed to Pain 2Health News:Newborns in Intensive Care Often Exposed to Pain 3Health News:Penn animal study identifies new DNA weapon against avian flu 2Health News:Penn animal study identifies new DNA weapon against avian flu 3Health News:Pediatric researchers find possible 'master switch' gene in juvenile arthritis 2Health News:Mental Test Spots Alzheimer's Risk 2Health News:Mental Test Spots Alzheimer's Risk 3
(Date:9/16/2014)... Alberta , Sept. 16, 2014  Wearable ... billion industry in less than two years, producing ... the way. A huge opportunity exists for leveraging ... Vivametrica ( http://vivametrica.com/our-video/ ) introduced a first-of-its-kind wearable ... based on years of clinical research linking activity ...
(Date:9/16/2014)...  Eli Lilly and Company (NYSE: ... to co-develop and commercialize AZD3293, an oral beta ... as a potential treatment for Alzheimer,s disease. ... by the accumulation of amyloid plaque in the ... development of beta-amyloid. Inhibiting BACE is expected to ...
(Date:9/15/2014)... PARIS and NEW YORK ... company Pharnext SAS and the Hereditary Neuropathy Foundation (HNF) ... increase the awareness around Charcot-Marie-Tooth (CMT) disease and support ... community. Pharnext will provide financial support ... design and development of a specific section in the ...
Breaking Medicine Technology:Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4
... Accelerated Community Oncology,Research Network(TM) (ACORN) will ... Guardian EDC(TM); PACE(TM) PRO System; and,proprietary oncology-focused ... Meeting,June 22-26, in Boston, MA., (Logo: ... 2008 the company announced its Contract Research ...
... iCAD, Inc. (Nasdaq:,ICAD), an industry-leading provider of ... cancer, today announced it has,initiated a clinical study ... partnership with ACR Image Metrix, a subsidiary of ... Image Metrix, having completed the,development portion of the ...
Cached Medicine Technology:ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 3iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: